EMEA-000200-PIP01-08-M07

Key facts

Invented name
Onglyza
Active substance
Saxagliptin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0051/2017
PIP number
EMEA-000200-PIP01-08-M07
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of type 2 diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
AstraZeneca AB
Sweden
Tel. +46 855322709
Fax +46 855326904
Email: paediatrics@astrazeneca.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating